Literature DB >> 26185625

A very unusual complication of amniocentesis.

Munawar Hayat1, Michael Hill1, David Kelly2, R Shane Tubbs3, Marios Loukas1.   

Abstract

The uses of amniocentesis are numerous, including determination of chromosomal abnormalities, lung maturity, and infections. A common complication of amniocentesis is loss of the pregnancy, but rare complications should be considered. The role of patient history and clinical observation of uncommon presentations are critical in the management of the patient.

Entities:  

Keywords:  Amniocentesis; complications; procedure; teratoma

Year:  2015        PMID: 26185625      PMCID: PMC4498839          DOI: 10.1002/ccr3.105

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


Amniocentesis is a well-known procedure performed during pregnancy for diagnostic and therapeutic purposes. Typical complications of the procedure include infection of the amniotic sac, preterm labor, respiratory distress, fetal deformities, trauma, alloimmunization, and failure of the puncture wound to heal properly. We present the case of a 13-month-old male who developed this primary tumor in the left hand thought to be a result of an amniocentesis complication during the second trimester of pregnancy. The diagnosis of this case proved difficult with multiple consultations due to the unconventional presentation of symptoms. The clinical impact of this case is evident as knowledge of this complication in fetal life can lead to a swifter and more accurate diagnosis as well as prevent further complications associated with malignant lesions.

Background

Amniocentesis is a routine procedure that is rarely the cause of a teratoma. Teratoma is a congenital tumor that is commonly formed by tissue represented by the three germ layers: the outer most layer ectoderm, the inner layer called the endoderm and mesoderm. The word teratoma has originated from the Greek language. The Greek word “teraton,” refers to monster and was used by the German physician Rudolph C. Virchow in his book on tumors, which was published in 1863 1. These tumors are either monodermal and highly specialized or in rare cases undergo malignant transformation 2. Typically, teratomas are classified as benign, heterogeneous collection of well-differentiated cells (mature), undifferentiated cells of embryonic origin (immature), teratoma with malignant transformation, and mixed germ cell tumors, which also includes malignant mixed type (also referred to as teratocarcinoma) 2. The specific type of tumor and its location depends on the age of the patient. Benign teratomas usually do not spread but rather they tend to grow aggressively. On the other hand, malignant teratomas are characterized by metastasis in addition to local aggressive growth 3. Specifically; teratomas in newborns are generally benign and local in their growth behavior. Some teratomas can gain malignancy, “depending on the maturity and other types of cells that may be involved 3.” The most common congenital tumor in a newborn is a sacrococcygeal teratoma, which has a highly favorable prognosis due to its early diagnosis (grossly visible), allowing for timely treatment 3. Unique germ cell sites such as the ovary, testicle, and even some unusual sites as the neck, stomach, and portions of the retroperitoneum may be sites for teratomas 3. Another common tumor in children is the yolk sac tumor, also known as endodermal sinus tumor (EST). The EST is the most common testicular tumor in children under 3 years of age 4. These tumors bear some histological resemblance to the yolk sac, allantois, and the embryonic mesenchyme, hence the nomenclature. Several studies have studied gene abnormalities associated with EST, one being hypermethylation of the RUNX3 gene (a transcription factor) and the second being associated with the overexpression of GATA-4, another transcription factor that regulates the differentiation of the yolk sac endoderm 5,6. Adult yolk sac tumors are often found in conjunction with other kinds of germ cell tumors, mostly teratomas, and embryonal carcinomas, however, infants usually present with the pure form of teratomas 7. The presentation of these tumors usually consists of no specific set of symptoms except for a painless testicular mass. Pure teratomas are usually benign, while the EST is malignant. Metastasis of the tumor is uncommon and results in >10% of the affected population of patients. Elevated levels of α feta protein occur in 75% of patients with teratocarcinoma (mixed germ cell tumor), embryonal cell carcinoma, and yolk sac carcinoma 4,7. Aggressive tumors in children are commonly treated with surgical resection and adjuvant chemotherapy, which has excellent prognostic results. However, other factors such as lower levels of alpha fetal protein and earlier stages of disease also carry a better prognosis. The following case is an atypical presentation of a mixed teratoma (teratocarcinoma) with yolk sac component secondary to a procedure.

Case Presentation

We report a 13-month-old African American male who presented with a mass on the dorsal left hand. The mass was not noticed until recently as it grew rapidly in size. No report of redness or pain associated with the lesion. The patient had no significant past medical history according to his parents. A complete prenatal, natal, and postnatal history revealed a complicated amniocentesis during the second trimester in 2012. The amniocentesis was done in a private clinic setting and much detailed information was not available. After further inquiry, the mother explained that there was minor contact of the needle with the fetus but no trauma or abnormalities were noted at the time or after several follow-ups.

Investigations

A biopsy was performed of the lesion and a fleshy, yellow-tan soft tissue measuring 2.5 × 2 × 0.5 cm was excised. The initial microscopic description of the soft tissue sections revealed that the tumor resembled Schiller–Duvall bodies. Further description of the mass included: pleomorphic malignant neoplasm with focal areas of the tumor that resembled differentiated and tubular structures and eosinophilic hyaline droplets present extracellularly within the cytoplasm that contained alpha fetoprotein. Chest X-ray (including skull), computed tomography (CT) scan, and abdominal ultrasound were unremarkable.

Differential diagnosis

The differential diagnoses considered in this case included synovial sarcoma, unusual sweat gland carcinoma, unusual appearing hemangiopericytoma, and a glomus tumor. Multiple consultations resulted in the final diagnosis to be mixed teratoma (teratocarcinoma) with yolk sac component.

Treatment

Based on the information at hand and the diagnosis it was determined to proceed with amputation of the left hand. A biopsy of the left axillary nodes was also performed at the time as well.

Outcome and follow-up

The patient recovered well postoperatively. The axillary lymph nodes yielded negative results for metastatic cells. The patient is now doing well and continuing to follow-up with his pediatrician.

Discussion

This case offered a patient with an extragonadal teratoma located in the upper extremity, inarguably an uncommon place. Extragonadal presentations of germ cell tumors are well recognized, occurring in the retroperitoneum, mediastinum, pineal, and suprasellar region 8. There was no evidence of a primary source for this malignant tumor, normally discovered by lymph node biopsy and at long-term follow-up (greater than 10 years) there were no additional sites of tumor growth. A classic feature of malignant, germ cell tumors (of the gonads) is a supraclavicular mass also known as Virchow's Node due to lymphadenopathy via lymphatic drainage. Routine biopsy of supraclavicular nodes has indeed been advocated as a staging procedure for patients with testicular tumors 9,10. In this case there was no evidence of testicular tumor and after amputation of the effected hand the biopsy results were negative. According to Colon and Upton, “diagnosing and treating pediatric hand tumors requires an understanding of unique features 11.” Most lesions of the upper extremities present with a definite history of trauma, but some, as the case presented herein, do not. The palmar surface of the hand was the most common site of the lesions. It is widely accepted that hand tumors in pediatric patients are rare and when found, diagnostic tests such as, CT, magnetic resonance imaging, and ultrasonography can provide help to identify specific diagnoses 12–15. However, most pediatric hand tumors are benign and painless and do not require surgical intervention 11. Sobanko et al. stated that “soft tissue tumors of the hand arise from skin, subcutaneous tissue, tendons, nerve, and blood vessels 16.” Tumors of the hand usually present differently, therefore, these must be treated differently than similar tumors on other areas of the body. Only 1–2% of primary tumors located in the hand are considered to be malignant, additionally the most common of these malignant tumors are squamous cell carcinoma 16. Metastatic tumors are rare in the hand, but they should be strongly considered in the differential as the prognosis is poor 10,15. Two-thirds of reported cases originate through malignancies of the lung, kidney, or head/neck, although not marked in this case 16. The crucial element in this case was a thorough history and physical examination. Once the chart was reviewed and it was revealed that the patient had undergone a complicated amniocentesis procedure during the second trimester, the diagnosis became much more apparent. The amniotic fluid contains fetal tissues/cells, which was likely extracted from the amniotic sac and inadvertently placed into the patient's left hand. Although amniocentesis is a routine procedure there are numerous complications that are associated with the procedure. Serious complications can result in miscarriage 17. Amniocentesis carries a risk of miscarriage, which is thought to be 1 out of every 200 procedures, however, a recent study has shown that this risk may be reduced, 1 in 1600 18,19. In comparison to chorionic villus sampling (CVS), the risk of miscarriage has reported to be more substantial, 1 out of 100 procedures. It is preferable to perform CVS up to four weeks earlier because the possibility of genetic defects is thought to be higher 20. Although very uncommon, one of the risks mentioned is fetal injury, secondary to trauma from the needle. Fetal trauma case reports have commonly reported disfigurements on the skin; nonetheless, cases have been reported inciting direct trauma to central nervous system causing bleeds, ocular disturbances, and injury to internal organ 21. In this clinical case, we believe that the fetus underwent trauma during the amniocentesis procedure, causing damage to the left hand of the fetus. Fetal limbs were found to be more commonly associated with needle contact compared to other fetal body parts 22. Most amniocentesis-related injuries occur when the procedure is performed in the late 2nd and 3rd trimesters. Petrikovsky and Kaplan reported an incidence of 0.4% when using constant ultrasound-guided amniocentesis 22. Prior to the use of synchronized ultrasound (U/S), a doctor's judgment was mainly based on the physical examination; it was performed blindly. Shortly after the restrictions of static U/S were uncovered, continuous visualization became the new movement in obstetric medicine. Jeanty et al. in 1983 described the use of real-time, simultaneous ultrasound-guided technique, with constant visualization of the needle, the amniotic fluid, and the fetus 23. The currently accepted procedure helps to improve the needle induction in relation to closely located organs of the mother 24. It also allows for better control and maneuverability of the needle angle during the procedure 24.” An NICHD-sponsored investigation showed that about 3.5% of pregnant women that elected for an amniocentesis during 1972 up to 1975 suffered from miscarriage after the procedure, which was significantly different from the controls (3.2%) who did not elect to have amniocenteses 25,26. Conversely, a British collaborative study during the same period (1973–1976) reported rates of fetal after the procedure to be notably greater than its controls (2.6% vs. 1%) 27. Similar results were found in a study from Denmark, where the miscarriage rate was 1.7% in females who had amniocentesis compared to 0.7% in the control group (P ≪ 0.05) 25. It is critical to realize that in all the previously discussed studies simultaneous ultrasound guidance was not used 22. Overall, the attributable risk for loss of the fetus secondary to amniocentesis in a normal population is closely 0.5% 24. Statistically, amniocentesis is considered to be a safe procedure with a complication rate affecting >2% of cases 21. However, the complications that can occur can potentially become very damaging to a family such as a debilitating injury to the fetus or a miscarriage 21. In this case, it proved detrimental to the patient as well as to his family. Therefore, amniocentesis should be performed with great care and attention to detail, to minimize complications that affect the lives of patients.

Conflict of Interest

None declared.
  20 in total

1.  Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat's placenta.

Authors:  G TEILUM
Journal:  Cancer       Date:  1959 Nov-Dec       Impact factor: 6.860

2.  Benign cystic teratomas of the ovary; a clinico-statistical study of 1,007 cases with a review of the literature.

Authors:  W F PETERSON; E C PREVOST; F T EDMUNDS; J M HUNDLEY; F K MORRIS
Journal:  Am J Obstet Gynecol       Date:  1955-08       Impact factor: 8.661

3.  Masses of the hand and wrist: detection and characterization with MR imaging.

Authors:  L A Binkovitz; T H Berquist; R A McLeod
Journal:  AJR Am J Roentgenol       Date:  1990-02       Impact factor: 3.959

4.  Transcription factor GATA-4 is expressed in pediatric yolk sac tumors.

Authors:  S Siltanen; M Anttonen; P Heikkilä; N Narita; M Laitinen; O Ritvos; D B Wilson; M Heikinheimo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  Ultrasonography for the diagnosis of soft tissue conditions in the hand.

Authors:  M Höglund; P Tordai; O Engkvist
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1991

6.  Supraclavicular node biopsy in testicular tumors.

Authors:  R E Donohue; R R Pfister; J W Weigel; O G Stonington
Journal:  Urology       Date:  1977-05       Impact factor: 2.649

7.  Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.

Authors:  A Tabor; J Philip; M Madsen; J Bang; E B Obel; B Nørgaard-Pedersen
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321

8.  Fetal complications of diagnostic amniocentesis: a review and report of a case with pneumothorax.

Authors:  L N Cook; R J Shott; B F Andrews
Journal:  Pediatrics       Date:  1974-03       Impact factor: 7.124

9.  Germ cell tumours confined to the supra-clavicular fossa: a report of two cases.

Authors:  N J Slevin; P D James; D A Morgan
Journal:  Eur J Surg Oncol       Date:  1985-06       Impact factor: 4.424

10.  Pregnancy loss rates after midtrimester amniocentesis.

Authors:  Keith A Eddleman; Fergal D Malone; Lisa Sullivan; Kim Dukes; Richard L Berkowitz; Yara Kharbutli; T Flint Porter; David A Luthy; Christine H Comstock; George R Saade; Susan Klugman; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Mary E D'Alton
Journal:  Obstet Gynecol       Date:  2006-11       Impact factor: 7.661

View more
  1 in total

1.  Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women.

Authors:  Fok-Moon Lum; Vipin Narang; Susan Hue; Jie Chen; Naomi McGovern; Ravisankar Rajarethinam; Jeslin Jl Tan; Siti Naqiah Amrun; Yi-Hao Chan; Cheryl Yp Lee; Tze-Kwang Chua; Wearn-Xin Yee; Nicholas Kw Yeo; Thiam-Chye Tan; Xuan Liu; Sam Haldenby; Yee-Sin Leo; Florent Ginhoux; Jerry Ky Chan; Julian Hiscox; Chia-Yin Chong; Lisa Fp Ng
Journal:  Clin Transl Immunology       Date:  2019-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.